BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37990035)

  • 1. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.
    Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
    Cell Mol Immunol; 2023 Dec; 20(12):1487-1498. PubMed ID: 37990035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a mouse model of ICF syndrome reveals enhanced CD19 activation in inducing hypogammaglobulinemia.
    Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of specific DNA binding by the transcription factor ZBTB24.
    Ren R; Hardikar S; Horton JR; Lu Y; Zeng Y; Singh AK; Lin K; Coletta LD; Shen J; Lin Kong CS; Hashimoto H; Zhang X; Chen T; Cheng X
    Nucleic Acids Res; 2019 Sep; 47(16):8388-8398. PubMed ID: 31226215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
    Kiaee F; Zaki-Dizaji M; Hafezi N; Almasi-Hashiani A; Hamedifar H; Sabzevari A; Shirkani A; Zian Z; Jadidi-Niaragh F; Aghamahdi F; Goudarzvand M; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):664-672. PubMed ID: 32533820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
    Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
    Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ZBTB24 protein domains and motifs for heterochromatin localization and transcriptional activation.
    Aktar S; Sasaki H; Unoki M
    Genes Cells; 2019 Nov; 24(11):746-755. PubMed ID: 31561277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
    Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Immunological Characterization of ICF Syndrome in Japan.
    Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
    J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZBTB24 regulates the apoptosis of human T cells via CDCA7/TRAIL-receptor axis.
    Qin XY; Feng J; Chen G; Dou XW; Dai XQ; Dong HL; Gong FY; Xiao F; Zhao Y; Gao XM; Wang J
    Biochem Biophys Res Commun; 2019 Jun; 514(1):259-265. PubMed ID: 31030944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
    Vukic M; Daxinger L
    Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
    Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
    J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
    Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
    Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the intersection of epigenetics, DNA repair, and immunology from studies of ICF syndrome, an inborn error of immunity.
    Unoki M
    Front Immunol; 2024; 15():1405022. PubMed ID: 38799442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
    Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
    J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
    Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
    J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
    [No Abstract]   [Full Text] [Related]  

  • 17. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
    Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
    Hu H; Chen C; Shi S; Li B; Duan S
    Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome.
    Helfricht A; Thijssen PE; Rother MB; Shah RG; Du L; Takada S; Rogier M; Moritz J; IJspeert H; Stoepker C; van Ostaijen-Ten Dam MM; Heyer V; Luijsterburg MS; de Groot A; Jak R; Grootaers G; Wang J; Rao P; Vertegaal ACO; van Tol MJD; Pan-Hammarström Q; Reina-San-Martin B; Shah GM; van der Burg M; van der Maarel SM; van Attikum H
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32865561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.